HUNTINGTON NATIONAL BANK - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$17,672
-13.2%
641
-5.3%
0.00%
Q2 2023$20,350
-18.5%
677
-1.7%
0.00%
Q1 2023$24,963
-0.3%
689
-1.9%
0.00%
Q4 2022$25,041
-10.6%
702
-13.8%
0.00%
Q3 2022$28,000
+16.7%
8140.0%0.00%
Q2 2022$24,000
+200.0%
814
+216.7%
0.00%
Q1 2022$8,000
+14.3%
2570.0%0.00%
Q4 2021$7,000
+40.0%
257
+49.4%
0.00%
Q3 2021$5,0000.0%1720.0%0.00%
Q2 2021$5,0000.0%1720.0%0.00%
Q1 2021$5,000
+25.0%
1720.0%0.00%
Q4 2020$4,0000.0%1720.0%0.00%
Q3 2020$4,0000.0%1720.0%0.00%
Q2 2020$4,000
-63.6%
172
-72.8%
0.00%
Q1 2020$11,000
+22.2%
633
+63.1%
0.00%
Q4 2019$9,000
-30.8%
388
-17.6%
0.00%
Q3 2019$13,000
-18.8%
4710.0%0.00%
Q2 2019$16,000
-89.8%
471
-89.5%
0.00%
-100.0%
Q1 2019$157,000
+946.7%
4,485
+881.4%
0.00%
Q4 2018$15,0000.0%457
+54.4%
0.00%
Q3 2018$15,000
-76.9%
296
-72.8%
0.00%
-100.0%
Q2 2018$65,000
+30.0%
1,089
-1.2%
0.00%0.0%
Q1 2018$50,000
+525.0%
1,102
+468.0%
0.00%
Q4 2017$8,000
-11.1%
194
-10.6%
0.00%
Q3 2017$9,0000.0%2170.0%0.00%
Q2 2017$9,0002170.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders